A pilot study of a metronomic chemotherapy regimen with weekly low-dose docetaxel for previously treated non-small cell lung cancer [0.03%]
每周小剂量多西他赛肺动脉化疗治疗晚期非小细胞肺癌的临床研究试点项目
Takashi Yokoi,Takeshi Tamaki,Toshiki Shimizu et al.
Takashi Yokoi et al.
Background: Low-dose metronomic (LDM) chemotherapy is a novel approach that involves frequent administration of a low dose of chemotherapeutic agent without a long interval. ...
Experience with carboplatin and etoposide maintenance chemotherapy in patients with extensive stage small cell lung cancer [0.03%]
顺铂和依托泊苷维持化疗治疗广泛期小细胞肺癌患者的疗效分析
Amaan Siddiqi,Huzefa Bahrain,Michael Auerbach
Amaan Siddiqi
Purpose: To determine whether maintenance therapy with carboplatin and etoposide improves progression-free and overall survival in patients with extensive stage small cell lung cancer, compared to the standard four to six...
Genome-wide gene expression analysis of chemoresistant pulmonary carcinoid cells [0.03%]
肺类癌药耐受细胞的基因组范围的基因表达分析
Ulrike Olszewski,Robert Zeillinger,Klaus Geissler et al.
Ulrike Olszewski et al.
Purpose: Carcinoids are highly chemoresistant tumors associated with a dismal prognosis. This study involved a comparison of the genome-wide gene expression pattern of a chemoresistant and a chemosensitive pulmonary carci...
Astragalus-containing Chinese herbal combinations for advanced non-small-cell lung cancer: a meta-analysis of 65 clinical trials enrolling 4751 patients [0.03%]
含黄芪的中药复方联合化疗治疗晚期非小细胞肺癌的Meta分析：基于65项临床研究4751例患者的证据评价
Jean Jacques Dugoua,Ping Wu,Dugald Seely et al.
Jean Jacques Dugoua et al.
Background: Non-small-cell lung cancer (NSCLC) is a leading cause of death. Interventions to reduce mortality in patients with NSCLC represent a patient-important field of research. Little is known about interventions use...